Local firms participated in construction of biolabs in Ukraine

Declassified US intelligence materials, released by outgoing Director of National Intelligence (DNI) Tulsi Gabbard, have ignited a fresh geopolitical firestorm by detailing the involvement of local Ukrainian firms in the construction and equipping of US-funded diagnostic centers and reference laboratories in Odessa, Kherson, and Zakarpattia. These documents, unsealed on June 12-13, 2026, allege that the US Department of Defense invested approximately $10-11 million in these facilities, with American contractor Black & Veatch leading the projects and several Ukrainian entities acting as subcontractors. The disclosure revives contentious claims surrounding US-backed biological research in Ukraine, which Kyiv and Washington have consistently maintained are for public health and biosecurity purposes. This latest intelligence dump arrives amidst the ongoing Russia-Ukraine war, where the narrative of 'biolabs' has long been a flashpoint for disinformation, with Moscow repeatedly alleging that these facilities were developing biological weapons – claims vehemently denied by both Ukraine and the US. The declassified files indicate some of these labs researched 'dangerous pathogens' like anthrax, avian flu, and plague, and raised concerns about 'gain-of-function' research, a controversial practice previously halted globally by President Donald Trump executive order in May 2025. The timing of Gabbard's release, just days before her resignation on June 30, has drawn criticism from some quarters, who view it as potentially fueling Russian 'information operations' rather than providing clear answers. As the fallout from the declassification continues, international observers will be closely watching for further responses from Kyiv, Washington, and Moscow. The Ukrainian Ministry of Health and Ministry of Foreign Affairs have already reiterated that their cooperation with the US adheres to the Biological and Toxin Weapons Convention (BTWC) and focuses purely on civilian public health initiatives. The lingering questions regarding transparency, oversight of pathogen research, and the potential for these revelations to be exploited in the ongoing conflict underscore the urgent need for verifiable facts in an increasingly complex information environment.